Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 29.9.2022Octapharma AB (OCP-S-1)3428BNuwiq 250 IU prášok a rozpúšťadlo na injekčný roztok (plv iol 1x250 IU+1x2,5 ml solv.+adapter inj.liek. (liek.inj.skl.+striek.inj.skl.napl.))28.9.2022O
 29.9.2022Mylan Ireland Limited (MNY)8959BRupatadine Mylan 10 mg tablety (tbl 50x10 mg (blis.PVC/PVDC/Al))29.9.2022O
 29.9.2022Viatris Limited (VIM)6931BCinacalcet Viatris 30 mg filmom obalené tablety (tbl flm 28x30 mg (blis.Al/PVDC/PVC))29.9.2022O
 29.9.2022Mylan Pharmaceuticals Limited (MLB-IE-1)6935BCinacalcet Mylan 60 mg filmom obalené tablety (tbl flm 28x60 mg (blis.Al/PVDC/PVC))29.9.2022O
 29.9.2022B.Braun Melsungen AG (BME)80553Braunol (sol der 1x1000 ml (fľ.PE))29.9.2022O
 29.9.2022AstraZeneca AB (AZC)5865DCalquence 100 mg tvrdé kapsuly (cps dur 60x100 mg (blis.Al/Al))29.9.2022U
 29.9.2022Teva B.V. (TEV-NL-4)66180Valsartan HCT Teva 160/25 mg (tbl flm 28x160 mg/25 mg (blis.PVC/PE/PVDC/Al))7.10.2022O
 28.9.2022Baxter Slovakia s.r.o. (BAX-SK)0384BEndoxan 200 mg prášok na injekčný roztok (plv ino 50x200 mg (liek.inj.skl.))1.10.2022R
 28.9.2022Baxter Slovakia s.r.o. (BAX-SK)0385BEndoxan 500 mg prášok na injekčný roztok (plv ino 6x500 mg (liek.inj.skl.))1.10.2022R
 28.9.2022Baxter Slovakia s.r.o. (BAX-SK)0387BEndoxan 1000 mg prášok na injekčný roztok (plv ino 5x1 g (liek.inj.skl.))1.10.2022R
 28.9.2022Accord Healthcare S.L.U (ACC-ES)5361BBortezomib Accord 3,5 mg prášok na injekčný roztok (plv ino 1x3,5 mg (liek.inj.skl.))1.12.2022Z
 28.9.2022GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o. (GAG-CZ)65951TheraFlu prechladnutie a chrípka (plo por 1x14 (5-vrst.vre.papier/PET/LDPE/Al/LDPE))26.9.2022Z
 28.9.2022Teva B.V. (TEV-NL-4)0458EAtorvastatín/Ezetimib Teva 20 mg/10 mg (tbl flm 30x20 mg/10 mg (blis.OPA/Al/PVC/Al))30.9.2022U
 28.9.2022Teva B.V. (TEV-NL-4)0466EAtorvastatín/Ezetimib Teva 20 mg/10 mg (tbl flm 90x20 mg/10 mg (blis.OPA/Al/PVC/Al))30.9.2022U
 28.9.2022Teva B.V. (TEV-NL-4)0478EAtorvastatín/Ezetimib Teva 40 mg/10 mg (tbl flm 30x40 mg/10 mg (blis.OPA/Al/PVC/Al))30.9.2022U

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)